These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8105483)

  • 1. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
    Altenberg GA; Young G; Horton JK; Glass D; Belli JA; Reuss L
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9735-8. PubMed ID: 8105483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
    Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
    J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
    Roepe PD; Wei LY; Cruz J; Carlson D
    Biochemistry; 1993 Oct; 32(41):11042-56. PubMed ID: 8105888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
    Altenberg GA; Vanoye CG; Horton JK; Reuss L
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
    Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
    Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
    Eytan GD; Regev R; Oren G; Assaraf YG
    J Biol Chem; 1996 May; 271(22):12897-902. PubMed ID: 8662680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells.
    Ouar Z; Lacave R; Bens M; Vandewalle A
    Cell Biol Toxicol; 1999 Apr; 15(2):91-100. PubMed ID: 10408356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
    Hoffman MM; Wei LY; Roepe PD
    J Gen Physiol; 1996 Oct; 108(4):295-313. PubMed ID: 8894978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
    Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
    Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
    Weaver JL; Szabo G; Pine PS; Gottesman MM; Goldenberg S; Aszalos A
    Int J Cancer; 1993 May; 54(3):456-61. PubMed ID: 7685326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
    Assaraf YG; Borgnia MJ
    Eur J Biochem; 1994 Jun; 222(3):813-24. PubMed ID: 7517866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
    Center MS
    Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
    Nielsen D; Skovsgaard T
    Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.
    Juranka PF; Zastawny RL; Ling V
    FASEB J; 1989 Dec; 3(14):2583-92. PubMed ID: 2574119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
    Castro AF; Altenberg GA
    Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function.
    Gupta S; Kim CH; Tsuruo T; Gollapudi S
    J Clin Immunol; 1992 Nov; 12(6):451-8. PubMed ID: 1363104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgp1 gene.
    Devine SE; Melera PW
    Cancer Chemother Pharmacol; 1994; 33(6):465-71. PubMed ID: 7907953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
    Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical aspects of P-glycoprotein-mediated multidrug resistance.
    Wadkins RM; Roepe PD
    Int Rev Cytol; 1997; 171():121-65. PubMed ID: 9066127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.